The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of cabozantinib in patients (pts) with relapsed or refractory metastatic urothelial carcinoma (mUC).
 
Andrea B. Apolo
No Relationships to Disclose
 
Howard L. Parnes
No Relationships to Disclose
 
Deneise C Francis
No Relationships to Disclose
 
Lisa M Cordes
No Relationships to Disclose
 
Marilise Berninger
No Relationships to Disclose
 
Elizabeth Lamping
No Relationships to Disclose
 
Rene Costello
No Relationships to Disclose
 
Jane B. Trepel
No Relationships to Disclose
 
Maria J Merino
No Relationships to Disclose
 
Les Folio
No Relationships to Disclose
 
Maria Liza Lindenberg
No Relationships to Disclose
 
William Douglas Figg
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
John Joseph Wright
No Relationships to Disclose
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
Yangmin M. Ning
No Relationships to Disclose
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology
 
Donald P. Bottaro
No Relationships to Disclose
 
William L. Dahut
No Relationships to Disclose
 
Piyush K. Agarwal
No Relationships to Disclose